Cooper Companies Inc (NYSE:COO) – Northcoast Research lifted their Q1 2019 EPS estimates for Cooper Companies in a research report issued on Tuesday, February 19th. Northcoast Research analyst D. Keiser now anticipates that the medical device company will earn $2.52 per share for the quarter, up from their previous forecast of $2.48. Northcoast Research also issued estimates for Cooper Companies’ Q4 2019 earnings at $3.15 EPS and FY2019 earnings at $11.71 EPS.
Cooper Companies (NYSE:COO) last announced its quarterly earnings data on Thursday, December 6th. The medical device company reported $2.87 earnings per share for the quarter, missing analysts’ consensus estimates of $2.96 by ($0.09). The firm had revenue of $651.50 million during the quarter, compared to analysts’ expectations of $645.25 million. Cooper Companies had a net margin of 5.52% and a return on equity of 17.70%. The company’s revenue for the quarter was up 16.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $2.65 EPS.
Shares of COO opened at $286.33 on Thursday. Cooper Companies has a 52-week low of $216.47 and a 52-week high of $288.51. The firm has a market capitalization of $13.98 billion, a price-to-earnings ratio of 24.90, a P/E/G ratio of 2.23 and a beta of 0.88. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.03 and a quick ratio of 1.16.
Large investors have recently modified their holdings of the stock. Essex Savings Bank acquired a new stake in shares of Cooper Companies during the 4th quarter worth about $25,000. Certified Advisory Corp acquired a new stake in shares of Cooper Companies during the 4th quarter worth about $25,000. Executive Wealth Management LLC acquired a new stake in shares of Cooper Companies during the 4th quarter worth about $34,000. Financial Gravity Companies Inc. purchased a new position in Cooper Companies during the 4th quarter valued at about $46,000. Finally, Rehmann Capital Advisory Group boosted its holdings in Cooper Companies by 24.3% during the 4th quarter. Rehmann Capital Advisory Group now owns 220 shares of the medical device company’s stock valued at $56,000 after acquiring an additional 43 shares during the period.
In other Cooper Companies news, Director Allan E. Rubenstein acquired 348 shares of the business’s stock in a transaction that occurred on Monday, December 10th. The stock was purchased at an average cost of $241.59 per share, with a total value of $84,073.32. Following the transaction, the director now owns 4,524 shares of the company’s stock, valued at $1,092,953.16. The transaction was disclosed in a filing with the SEC, which is available at this link. 1.70% of the stock is currently owned by company insiders.
The firm also recently disclosed a semiannual dividend, which was paid on Friday, February 8th. Investors of record on Tuesday, January 22nd were given a dividend of $0.03 per share. This represents a dividend yield of 0.02%. The ex-dividend date was Friday, January 18th. Cooper Companies’s payout ratio is 0.52%.
About Cooper Companies
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
See Also: Leveraged Buyout (LBO) Explained
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.